史赛克Stryker Corporation（SYK）2025年第四季度及全年业绩报告「NYSE」（英文版）（10页）.pdf

1、 1 1941 Stryker Way Portage,MI 49002 Press release Number:26-02 Date:January 29,2026 STRYKER REPORTS 2025 OPERATING RESULTS AND 2026 OUTLOOK Portage,Michigan-January 29,2026-Stryker(NYSE:SYK)reported operating results for the fourth quarter and full year of 2025:Fourth Quarter Results Reported net s

2、ales increased 11.4%to$7.2 billion Organic net sales increased 11.0%Reported operating income margin of 25.2%Adjusted operating income margin(1)increased 100 bps to 30.2%Reported EPS increased 56.0%to$2.20 Adjusted EPS(1)increased 11.5%to$4.47 Fourth Quarter Net Sales Growth Overview Reported Foreig

3、n Currency Exchange Constant Currency Acquisitions/Divestitures Organic MedSurg and Neurotechnology 17.5%0.9%16.6%4.0%12.6%Orthopaedics 2.2 1.3 0.9 (7.5)8.4 Total 11.4%1.0%10.4%(0.6)%11.0%Full Year Results Reported net sales increased 11.2%to$25.1 billion Organic net sales increased 10.3%Reported op

4、erating income margin of 19.5%Adjusted operating income margin(1)increased 100 bps to 26.3%Reported EPS increased 8.2%to$8.40 Adjusted EPS(1)increased 11.8%to$13.63 Full Year Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions/Divestitures Organic MedSurg and

5、Neurotechnology 15.7%0.3%15.4%4.7%10.7%Orthopaedics 4.3 0.5 3.8 (5.7)9.5 Total 11.2%0.5%10.7%0.4%10.3%“We had an outstanding finish to 2025,driving double-digit sales and adjusted earnings per share growth for the fourth quarter and full year while delivering adjusted operating margin expansion of a

6、t least 100 basis points for the second consecutive year,”said Kevin A.Lobo,Chair and CEO,Stryker.“Having surpassed$25 billion in revenue,we enter 2026 with significant momentum and are poised to continue delivering growth at the high end of MedTech.I want to thank our teams for driving exceptional